Skip to content
OpenCapital
Get started

CONMED CNMD United States — Net Sales

Similar metrics at other companies

Enovis logo
ENOVUnited States — Net Sales
$323.83M+4.0%
Avanos Medical logo
AVNSUnited States — Net Sales
$130.8M-1.1%
Globus Medical logo
GMEDUnited States — Net Sales
$604.89M+25.0%
Medtronic logo
MDTUnited States — Net Sales
$4.87B+7.1%
Baxter International logo
BAXUnited States — Net Sales
$1.44B-3.7%
Edwards Lifesciences logo
EWUnited States — Net Sales
$937.6M+11.8%

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.07B-34.0%
Enterprise value$1.89B-23.5%
P/E19.4×+5.8×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's united states — net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's united states — net sales?
CONMED (CNMD) reported united states — net sales of $173.06M in Q1 2026.
How has CONMED's united states — net sales changed year-over-year?
CONMED's united states — net sales decreased by 5.8% year-over-year, from $183.76M to $173.06M.
What is the long-term trend for CONMED's united states — net sales?
Over 4 years (2021 to 2025), CONMED's united states — net sales has grown at a 8.8% compound annual growth rate (CAGR), from $552.53M to $774.59M.
What does united states — net sales mean?
This metric represents the total revenue generated from the sale of medical devices and surgical equipment within the United States geographic market. It serves as a primary indicator of the company's domestic market penetration and the demand for its orthopedic and general surgery product portfolios. Growth in this figure reflects successful commercial execution and the ability to capture market share within the U.S. healthcare system.